Skip to content

Effect of nutritional support therapy on surgical outcome of maxillofacial disease in patients with geriatric sarcopenia with low plasma TTR level

Effect of nutritional support therapy on surgical outcome of maxillofacial disease in patients with geriatric sarcopenia with low plasma TTR level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056600
Enrollment
Unknown
Registered
2022-02-09
Start date
2023-01-08
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

Group 1:nutritional support therapy
Group 2:none

Sponsors

Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 65 years, regardless of gender; 2. Basic communication and understanding skills; 3. Elective surgery; 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Poor health status can not tolerate surgery and oxacin; 3. Lack of function of vital organs; 4. Patients with Parkinson's disease, depression, or severe cognitive dysfunction who cannot cooperate with the measurement of relevant indicators; 5. Unable to move, unable to move, or suffering from muscle or joint diseases; 6. Bioelectrical impedance measurement is contraindicated (such as pacemaker implantation) or affects the accuracy of measurement results.

Design outcomes

Primary

MeasureTime frame
Skeletal muscle index;Blood white cell count;Hemoglobin;Immunoglobulin;Total protein;Transthyretin;

Countries

China

Contacts

Public ContactCai Wenwei

Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

13564084838@139.com+86 13564084838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026